News search
Research 5 Jun 2025 This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. |
Research 2 Jun 2025 A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models. |
Research 31 May 2025 Dr. Joseph Hill holds the James T. Willerson, M.D., Chair in Cardiovascular Disease and the Frank M. Ryburn Jr. Chair in Cardiac Research at the University of Texas Southwestern Medical Center |
Research 28 Apr 2025 Prof. Daniel Ketelhuth leads a research team at the University of Southern Denmark |
Research 14 Apr 2025 A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer |
Research 9 Apr 2025 A CNIC team has developed an innovative gene therapy strategy for arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly inherited condition that particularly affects young men |
About the CNIC 8 Apr 2025 The system provides specialised answers to biomedical questions, ensuring data privacy by operating exclusively within the CNIC |
Research 2 Apr 2025 Scientists at the CNIC and the University of Bern have found that heart surgery in male mice early in life creates a "memory" passed down to the next generation. Published in Circulation, the study suggests that a parental history of heart surgery should be considered when evaluating cardiovascular health in descendants. |
Research 31 Mar 2025 The DapaTAVI study, conducted in 39 Spanish hospitals and coordinated by the CNIC, marks a breakthrough in cardiovascular research and could transform the treatment of these patients |
Research 19 Mar 2025 The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions |
- 1 of 19
- next ›